BioVie Inc., a Nevada corporation, has announced its intention to hold a Special Meeting of Stockholders on July 29, 2024, in a virtual format. The meeting will address two key proposals: the authority for a reverse stock split of the company's common stock at a ratio between 1-for-6 and 1-for-10, and the discretionary authority to adjourn the meeting if necessary to solicit additional proxies if there are insufficient votes to approve the reverse stock split. The Board of Directors has recommended stockholders to vote in favor of both proposals. The record date for determining stockholders entitled to vote at the Special Meeting has been set for June 13, 2024. The company has provided instructions on how stockholders can participate in the virtual meeting...Show More

BioVie Inc., a Nevada corporation, has announced its intention to hold a Special Meeting of Stockholders on July 29, 2024, in a virtual format. The meeting will address two key proposals: the authority for a reverse stock split of the company's common stock at a ratio between 1-for-6 and 1-for-10, and the discretionary authority to adjourn the meeting if necessary to solicit additional proxies if there are insufficient votes to approve the reverse stock split. The Board of Directors has recommended stockholders to vote in favor of both proposals. The record date for determining stockholders entitled to vote at the Special Meeting has been set for June 13, 2024. The company has provided instructions on how stockholders can participate in the virtual meeting, vote, and submit questions. The reverse stock split aims to increase the per-share trading price of BioVie's common stock to comply with Nasdaq's continued listing requirements. The Board of Directors will determine the exact ratio of the reverse stock split if the proposal is approved. The reverse stock split is not intended to reduce the number of authorized shares of common stock or preferred stock, nor will it alter the par values of these stocks.